Vitamin K2 in bone metabolism and osteoporosis.
This article covers in vitro, in vivo, and human data on the positive effect of vitamin K2 on osteoporosis. Data is available on vitamin K2 for osteoporosis caused by a number of conditions, including postmenopausal osteoporosis, Parkinson's disease, biliary cirrhosis, stroke, and drug-induced osteoporosis. The activity of vitamin K2 involves both an increase in the bone-building process and a separate decrease in the bone-loss process. Vitamin K2 exerts a more powerful influence on bone than vitamin K1, and should be considered for prevention or treatment in those conditions known to contribute to osteoporosis.
Plaza
Steven M
SM
Oncology Department, Bastyr University, Kenmore, Washington, USA.
Lamson
Davis W
DW
D000818:Animals; D001851:Bone Diseases, Metabolic / Q000209:etiology / Q000517:prevention & control; D004195:Disease Models, Animal; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy* / Q000517:prevention & control; D024482:Vitamin K 2 / Q000378:metabolism / Q000627:therapeutic use*
D024482:Vitamin K 2